M Svanbom, L Rombo, L Gustafsson. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Antimalarials/adverse effectsDrug Combinations/adverse effectsDrug Combinations/therapeutic useHumansLung Diseases/chemically inducedMalaria/prevention & controlMaleMiddle AgedPyrimethamine/adverse effectsPyrimethamine/therapeutic useSulfadoxine/adverse effectsSulfadoxine/therapeutic useSulfanilamides/adverse effects
Substances: See more » AntimalarialsDrug CombinationsSulfanilamidesfanasil, pyrimethamine drug combinationSulfadoxinePyrimethamine
Year: 1984 PMID: 6428585 PMCID: PMC1441758 DOI: 10.1136/bmj.288.6434.1876
Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN: 0267-0623